Until Labs
PrivateLast Round
Series A
Sep 22, 2025
Total Funding Raised
$106M
Company Overview
Until Labs is a biotechnology company that develops perfusion hardware, cryoprotective agents, and rewarming infrastructure for organ-scale reversible cryopreservation.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Advanced Materials, Precision Medicine
Business Model
B2B
Customer Profile
Hardware + Subscription, Usage-Based SaaS, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Until Labs Comparables
Compare Until Labs with similar companies based on industry and business-model similarity.
Until Labs Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Sep 22, 2025 | ||||
| Seed | Jun 6, 2024 |
Until Labs Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Field Ventures | Series A |
| Founders Fund | Series A |
| Lux Capital | Series A |
Until Labs Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Until Labs's valuation, stock price, and market status.